329 related articles for article (PubMed ID: 22990676)
1. Myoblasts derived from normal hESCs and dystrophic hiPSCs efficiently fuse with existing muscle fibers following transplantation.
Goudenege S; Lebel C; Huot NB; Dufour C; Fujii I; Gekas J; Rousseau J; Tremblay JP
Mol Ther; 2012 Nov; 20(11):2153-67. PubMed ID: 22990676
[TBL] [Abstract][Full Text] [Related]
2. Engraftment of human induced pluripotent stem cell-derived myogenic progenitors restores dystrophin in mice with duchenne muscular dystrophy.
He R; Li H; Wang L; Li Y; Zhang Y; Chen M; Zhu Y; Zhang C
Biol Res; 2020 May; 53(1):22. PubMed ID: 32430065
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of myogenic and muscle repair capacities of human adipose-derived stem cells with forced expression of MyoD.
Goudenege S; Pisani DF; Wdziekonski B; Di Santo JP; Bagnis C; Dani C; Dechesne CA
Mol Ther; 2009 Jun; 17(6):1064-72. PubMed ID: 19352326
[TBL] [Abstract][Full Text] [Related]
4. Fetal skeletal muscle progenitors have regenerative capacity after intramuscular engraftment in dystrophin deficient mice.
Sakai H; Sato T; Sakurai H; Yamamoto T; Hanaoka K; Montarras D; Sehara-Fujisawa A
PLoS One; 2013; 8(5):e63016. PubMed ID: 23671652
[TBL] [Abstract][Full Text] [Related]
5. Cell-lineage regulated myogenesis for dystrophin replacement: a novel therapeutic approach for treatment of muscular dystrophy.
Kimura E; Han JJ; Li S; Fall B; Ra J; Haraguchi M; Tapscott SJ; Chamberlain JS
Hum Mol Genet; 2008 Aug; 17(16):2507-17. PubMed ID: 18511457
[TBL] [Abstract][Full Text] [Related]
6. Proinflammatory macrophages enhance the regenerative capacity of human myoblasts by modifying their kinetics of proliferation and differentiation.
Bencze M; Negroni E; Vallese D; Yacoub-Youssef H; Chaouch S; Wolff A; Aamiri A; Di Santo JP; Chazaud B; Butler-Browne G; Savino W; Mouly V; Riederer I
Mol Ther; 2012 Nov; 20(11):2168-79. PubMed ID: 23070116
[TBL] [Abstract][Full Text] [Related]
7. Duchenne muscular dystrophy hiPSC-derived myoblast drug screen identifies compounds that ameliorate disease in mdx mice.
Sun C; Choi IY; Rovira Gonzalez YI; Andersen P; Talbot CC; Iyer SR; Lovering RM; Wagner KR; Lee G
JCI Insight; 2020 Jun; 5(11):. PubMed ID: 32343677
[TBL] [Abstract][Full Text] [Related]
8. Myogenic differentiation of muscular dystrophy-specific induced pluripotent stem cells for use in drug discovery.
Abujarour R; Bennett M; Valamehr B; Lee TT; Robinson M; Robbins D; Le T; Lai K; Flynn P
Stem Cells Transl Med; 2014 Feb; 3(2):149-60. PubMed ID: 24396035
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo gene editing of the dystrophin gene in muscle stem cells mediated by peptide nucleic acid single stranded oligodeoxynucleotides induces stable expression of dystrophin in a mouse model for Duchenne muscular dystrophy.
Nik-Ahd F; Bertoni C
Stem Cells; 2014 Jul; 32(7):1817-30. PubMed ID: 24753122
[TBL] [Abstract][Full Text] [Related]
10. Efficient derivation and inducible differentiation of expandable skeletal myogenic cells from human ES and patient-specific iPS cells.
Maffioletti SM; Gerli MF; Ragazzi M; Dastidar S; Benedetti S; Loperfido M; VandenDriessche T; Chuah MK; Tedesco FS
Nat Protoc; 2015 Jul; 10(7):941-58. PubMed ID: 26042384
[TBL] [Abstract][Full Text] [Related]
11. Nanotopography-responsive myotube alignment and orientation as a sensitive phenotypic biomarker for Duchenne Muscular Dystrophy.
Xu B; Magli A; Anugrah Y; Koester SJ; Perlingeiro RCR; Shen W
Biomaterials; 2018 Nov; 183():54-66. PubMed ID: 30149230
[TBL] [Abstract][Full Text] [Related]
12. Pluripotent stem cell-induced skeletal muscle progenitor cells with givinostat promote myoangiogenesis and restore dystrophin in injured Duchenne dystrophic muscle.
Xuan W; Khan M; Ashraf M
Stem Cell Res Ther; 2021 Feb; 12(1):131. PubMed ID: 33579366
[TBL] [Abstract][Full Text] [Related]
13. MyoD is required for myogenic stem cell function in adult skeletal muscle.
Megeney LA; Kablar B; Garrett K; Anderson JE; Rudnicki MA
Genes Dev; 1996 May; 10(10):1173-83. PubMed ID: 8675005
[TBL] [Abstract][Full Text] [Related]
14. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
15. Converting pathological cells to therapeutic ones: an odyssey through pluripotency.
Vilquin JT
Mol Ther; 2012 Nov; 20(11):2012-4. PubMed ID: 23131852
[No Abstract] [Full Text] [Related]
16. Induction of CCAAT/Enhancer-Binding Protein β Expression With the Phosphodiesterase Inhibitor Isobutylmethylxanthine Improves Myoblast Engraftment Into Dystrophic Muscle.
Lala-Tabbert N; Fu D; Wiper-Bergeron N
Stem Cells Transl Med; 2016 Apr; 5(4):500-10. PubMed ID: 26941360
[TBL] [Abstract][Full Text] [Related]
17. Stem cell therapies to treat muscular dystrophy: progress to date.
Meregalli M; Farini A; Parolini D; Maciotta S; Torrente Y
BioDrugs; 2010 Aug; 24(4):237-47. PubMed ID: 20623990
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cells derived from human induced pluripotent stem cells improve the engraftment of myogenic cells by secreting urokinase-type plasminogen activator receptor (uPAR).
Elhussieny A; Nogami K; Sakai-Takemura F; Maruyama Y; Takemura N; Soliman WT; Takeda S; Miyagoe-Suzuki Y
Stem Cell Res Ther; 2021 Oct; 12(1):532. PubMed ID: 34627382
[TBL] [Abstract][Full Text] [Related]
19. Initial failure in myoblast transplantation therapy has led the way toward the isolation of muscle stem cells: potential for tissue regeneration.
Urish K; Kanda Y; Huard J
Curr Top Dev Biol; 2005; 68():263-80. PubMed ID: 16125002
[TBL] [Abstract][Full Text] [Related]
20. PITX2 Enhances the Regenerative Potential of Dystrophic Skeletal Muscle Stem Cells.
Vallejo D; Hernández-Torres F; Lozano-Velasco E; Rodriguez-Outeiriño L; Carvajal A; Creus C; Franco D; Aránega AE
Stem Cell Reports; 2018 Apr; 10(4):1398-1411. PubMed ID: 29641992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
